Using new technologies for improving psychotropic medication adherence
-
1
Freelancer, Cyprus
-
2
University of Cyprus, Department of Psychology, Cyprus
-
3
University College London, Department of Applied Health Research, United Kingdom
-
4
Cocoon Creations Services Ltd, Cyprus
-
5
University of Crete, Department of Psychology, Greece
Background: Approximately one out of two patients do not take their medication three months after therapy starts; while in patients with mental disorders this number varies. The WHO published a guide for clinicians, advising them to develop strategies for improving medication adherence.
Aims: The aim of this project is to develop a smartphone application that will help patients adhere to their psychotropic medication and clinicians to keep track of their patients’ adherence.
Methods: In Phase I we will design an application based on scientific evidence and employ software and psychological (i.e. cognitive behavioural therapy) techniques to inform the applications’ features. In Phase II we will use patient and clinical focus groups to validate in the process the applications’ usability and effectiveness.
Results: We expect to develop a framework to assess the feasibility and usability of the application’s features. We also expect to have a first version of the application, which will be used in further studies using evaluation methodologies to update its content. Project is in the early stages of development.
Conclusions: Implementing such an app will lead to an effective and possibly low cost method for improving psychotropic medication adherence with significant benefits for both patients and clinicians. The applications’ integration with usual care will lead to social Benefits like higher quality of care, clinical effectiveness, reduced healthcare costs and time consumption, advantages of online possibilities and better patient outcomes like quality of life and patient satisfaction with care provision.
Supplementary Material: Technological aspects of the application
• The user will be able to organise their medication schedule (patient user) or monitor patients’ adherence (clinician user) using their smartphone or computer.
• In order to store and access information that are related to several drugs or medicines a Database Management System (DBMS) will be required.
• To ensure that users have the latest information regarding existing drugs on their device, the application will access the remote database in regular time intervals to check if data stored in the user’s device have changed (or deleted) from the remote database.
• Our implementation will support the communication between different smart-phone devices (client-server model).
• Our implementation will be highly secure in order to protect data privacy of its users.
Keywords:
Medication Adherence,
mHealth,
Smartphone application,
Psychotropic Drugs,
Compliance,
New technologies,
Health Psychology,
Doctor-patient communication,
mobile application development,
Pharmacy
Conference:
2nd Behaviour Change Conference: Digital Health and Wellbeing, London, United Kingdom, 24 Feb - 25 Feb, 2016.
Presentation Type:
Poster presentation
Topic:
Academic
Citation:
Iniatis
G,
Georgiou
G,
Kassianos
AP,
Nicolaou
S and
Papaconstantinou
E
(2016). Using new technologies for improving psychotropic medication adherence.
Front. Public Health.
Conference Abstract:
2nd Behaviour Change Conference: Digital Health and Wellbeing.
doi: 10.3389/conf.FPUBH.2016.01.00114
Copyright:
The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers.
They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.
The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.
Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.
For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.
Received:
26 Nov 2015;
Published Online:
09 Jan 2016.
*
Correspondence:
Dr. Angelos P Kassianos, University College London, Department of Applied Health Research, London, United Kingdom, ang.kassianos@gmail.com